ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3167

Association of the Apolipoprotein A1-C3-A4 Gene Cluster with the Risk of Gout: Evidence for a Causal Role in Gout

Tony R. Merriman1, Amanda Phipps-Green2, Ruth Topless2, Malcolm D. Smith3, Catherine Hill4, Susan Lester4, Maureen Rischmueller5, Matthijs Janssen6, Tim Jansen7, Leo A. Joosten8, Timothy Radstake9, Philip L. Riches10, Anne-Kathrin Tausche11, Frederic Lioté12, Alex So13,14, Andre M. van Rij2, Gregory T. Jones15, Sally McCormick16, Andrew Harrison2, Lisa K. Stamp17, Nicola Dalbeth18 and Humaira Rasheed16, 1Biochemistry Dept, PO Box 56, University of Otago, Dunedin, New Zealand, 2University of Otago, Dunedin, New Zealand, 3Rheumatology, Repatriation General Hospital, Adelaide, Australia, 4Rheumatology Unit, The Queen Elizabeth Hospital, Woodville, Australia, 5Rheumatology, Queen Elizabeth Hospital, Adelaide, Australia, 6Rheumatology Dept, Ziekenhuis Rijnstate, Arnhem, Netherlands, 7P O Box 581, Haarlem, Netherlands, 8Department of Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 9Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 10Centre for Genomic and Experimental Medicine, Western General Hospital, Edinburgh, United Kingdom, 11Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Germany, 12Rheumatology Department; Inserm UMR-S606; Paris-Diderot University, hôpital Lariboisiere, Paris, France, 13Service De Rhumatologie, CHUV, Lausanne, Switzerland, 14Department of Rheumatology, CHUV, Lausanne, Switzerland, 15Surgery, University of Otago, Dunedin, New Zealand, 16Department of Biochemistry, University of Otago, Dunedin, New Zealand, 17Medicine, University of Otago, Christchurch, Christchurch, New Zealand, 18Department of Medicine, University of Auckland, Auckland, New Zealand

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: gout, risk and uric acid

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Metabolic and Crystal Arthropathies II: Mechanisms and Associations

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Gout is caused by an inflammatory response to monosodium urate (MSU) crystals and is associated with elevated triglyceride and very low density lipoprotein levels. There is evidence that suggests apolipoprotein coating of MSU crytsals modulates the inflammatory response. Association of the apolipoprotein A1-C3-A4 gene cluster with gout has previously been reported. To investigate a possible causal role for this locus in gout we tested the association of genetic variants from APOA1 and APOC3 with gout. 

Methods: Testing of rs670 (APOA1) and rs5128 (APOC3) was undertaken in 2452 controls and 2690 clinically-ascertained gout cases of European and of New Zealand Polynesian (Māori and Pacific) ancestry. Data from the publically-available Atherosclerosis Risk in Communities (n=5367) study and the Framingham Heart Study (n=2984) were also analyzed. Multivariate adjusted logistic and linear regression was used to test the association of SNPs with gout risk, serum urate, triglyceride and high-density lipoprotein cholesterol (HDL-C).

Results: In Europeans and Polynesians, consistent with previous studies, both SNPs were associated with HDL-C (P≤0.027) and rs5128 was associated with triglyceride levels (P≤0.006). There was no evidence for association of rs670 or rs5128 with the risk of gout in Europeans (ORT allele=1.11, P=0.059; OR=1.01G allele, P=0.91 respectively). In contrast, in Polynesians the T-allele of rs670 (APOA1) increased the risk of gout (OR=1.53, P=4.88×10-6) and the G-allele of rs5128 (APOC3) decreased the risk of gout (OR=0.86, P=0.026). Association in Polynesians was independent of any effect of rs670 and rs5128 on triglyceride and HDL-C levels. There was no evidence for association of either SNP with serum urate levels in Europeans or Polynesians (P≥0.10). 

Conclusion: The data supports the hypothesis that the apolipoprotein A1-C3-A4 gene cluster plays a causal role in the inflammatory response in gout. The effect was specific to Polynesians in this study and could indicate a pathogenic process, outside of the inherent hyperuricaemia present in Polynesians, that contributes to the increased prevalence of gout in this population group.


Disclosure: T. R. Merriman, None; A. Phipps-Green, None; R. Topless, None; M. D. Smith, None; C. Hill, None; S. Lester, None; M. Rischmueller, None; M. Janssen, None; T. Jansen, None; L. A. Joosten, None; T. Radstake, None; P. L. Riches, Menarini, 2; A. K. Tausche, None; F. Lioté, None; A. So, None; A. M. van Rij, None; G. T. Jones, None; S. McCormick, None; A. Harrison, None; L. K. Stamp, None; N. Dalbeth, None; H. Rasheed, None.

To cite this abstract in AMA style:

Merriman TR, Phipps-Green A, Topless R, Smith MD, Hill C, Lester S, Rischmueller M, Janssen M, Jansen T, Joosten LA, Radstake T, Riches PL, Tausche AK, Lioté F, So A, van Rij AM, Jones GT, McCormick S, Harrison A, Stamp LK, Dalbeth N, Rasheed H. Association of the Apolipoprotein A1-C3-A4 Gene Cluster with the Risk of Gout: Evidence for a Causal Role in Gout [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/association-of-the-apolipoprotein-a1-c3-a4-gene-cluster-with-the-risk-of-gout-evidence-for-a-causal-role-in-gout/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-the-apolipoprotein-a1-c3-a4-gene-cluster-with-the-risk-of-gout-evidence-for-a-causal-role-in-gout/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology